Itaconix plc

Itaconix plc

180.00
GBX
0.00
(0.00%)
1.50BMarket Cap
Mar 30Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.97
1.6
0.04
0.23
0.47
0.28
0.24
0.48
0.3
0.62
0.58
0.48
0.78
- -
Basic EPS, GAAP
-9.7
-6.75
-2.51
-4.53
-8.54
-3.13
-0.25
-0.24
-0.05
-0.27
-0.11
-0.15
-0.1
- -
Free Cash Flow per Basic Share
-8.25
-7.57
-3.92
-4.16
-4.29
-2.21
-0.35
-0.17
-0.24
-0.03
-0.16
-0.23
-0.14
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
29.44
19.29
14.44
10.16
3.34
0.05
-0.19
-0.07
0.07
-0.09
0.83
0.68
0.61
0.59
Tangible Book Value per Share
29.44
19.29
14.44
3.05
3.34
0.05
-0.19
-0.07
0.07
-0.09
0.83
0.66
0.59
0.57
Basic Weighted Avg Shares
1
2
2
2
2
3
5
7
9
9
13
13
13
13
Sales/Revenue/Turnover
1
2
- -
- -
1
1
1
3
3
6
8
7
10
- -
Operating Margin (%)
-1,037.31
-431.02
-9,666.67
-1,818.25
-935.62
-643.13
-220.96
-42.86
-78.12
-41.37
-19.71
-33.6
-9.91
- -
Depreciation Expense
1
- -
- -
1
17
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-14
-10
-4
-9
-19
-10
-1
-2
- -
-2
-2
-2
-1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1,000.76
-420.25
-6,637.04
-2,005.61
-1,833.82
-1,120.09
-105.43
-50
-17.53
-43.98
-19.53
-31.09
-13.14
- -
Working Capital
44
29
22
13
7
3
1
1
1
-1
9
8
7
7
LT Debt
- -
- -
- -
- -
- -
- -
1
1
- -
- -
2
2
2
2
Total Equity
44
30
23
22
7
- -
-1
-1
1
-1
11
9
8
8
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-29.04
-28.17
-14.88
-39.08
-126.56
-261.78
- -
- -
- -
- -
- -
-19.82
-15.85
- -

Capital Structure

USD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
21
20
20

Working Capital

USD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
11
10
10
Cash, Cash Equivalents & STI
6
4
5
Accounts Receivable, Net
1
2
2
Inventories
4
4
3
Total Current Liabilities
3
3
3
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-264.77%
-400.01%
-10.27%
Free Cash Flow
59.16%
136.14%
-41.08%
Net Income, GAAP
45.47%
66.24%
-31.75%
Sales/Revenue/Turnover
113.73%
35.83%
61.45%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
7
2025
- -
- -
10
2026
- -
- -
- -

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.15
2025
- -
- -
-0.1
2026
- -
- -
- -

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
John Roger Shaw
Full Time Employees
28
Sector
Process industries
Industry
Chemicals: major diversified
Address
2 Marin Way London NH United Kingdom 03885
IPO Date
Jul 10, 2012
Business
Itaconix plc develops and manufactures proprietary plant-based specialty polymers that improve the performance and sustainability of consumer products, primarily serving home care, personal care, paints, coatings, and adhesives markets. Its core product offerings include multifunctional scale inhibitors for detergents under the Itaconix® brand, odour-neutralizing polymers marketed as VELAFRESH® and ITACONIX® ONZ™ series, and new specialty monomers and binders launched under the BIOAsterix® line targeting high-value industrial coatings and adhesives sectors. The company operates through two main segments: Performance Ingredients and Formulated Solutions, delivering ingredients globally, with commercial presence in North America, Europe, and Asia. Itaconix also recently initiated the SPARX™ innovation program aimed at accelerating the development and market adoption of new plant-based ingredient formulations in collaboration with other specialty ingredient firms and consumer brands. Founded in 2005 and headquartered in Stratham, New Hampshire, Itaconix transitioned from its former name Revolymer plc in 2017 and has expanded its geographic and product footprint since. Recent major developments include a significant revenue growth trajectory with a 73% increase in H1 2025 revenues to $4.8 million, driven largely by cleaning product sales and initial traction in formulated product offerings through SPARX™. In June 2025, Itaconix commercially launched the BIOAsterix® product line, adding a third distinct revenue stream beyond its cleaning and formulated solutions businesses. The company also extended and expanded its global supply and marketing collaboration with Croda Inc., including a new ingredient focused on odour control in fabric cleaning. Itaconix has broadened regulatory approvals in Australia, New Zealand, South Korea, Europe, and China, supporting global expansion. The firm invests in manufacturing improvements to enhance efficiency and packaging, maintaining production capacity in the U.S. without plans for new facilities. The expanded product portfolio now includes 17 proprietary products protected by 16 patent families, underpinning sustainable growth in multiple segments. Itaconix’s products are aimed at consumer and industrial customers seeking to reduce environmental impact and enhance the efficacy of cleaning, hygiene, beauty, and coating products. The SPARX™ program targets launching at least 10 new consumer products by the end of 2025, collaborating with ingredient suppliers, contract manufacturers, and brands. The company’s strategic focus is on regaining and expanding market share in North America and Europe for detergent polymers, increasing hygiene and beauty segment sales, and establishing new applications for odour neutralization and industrial use. Its strong balance sheet, proprietary technology platform, expanding product pipeline, and global regulatory footprint position Itaconix for sustained revenue growth and profitability advancement in the specialty polymer space. The company remains vigilant on macroeconomic and trade policy influences while driving innovation and commercial partnerships. This comprehensive portfolio and strategic momentum reflect Itaconix plc’s leadership in sustainable, plant-based specialty polymers for global consumer and industrial markets, with ongoing expansion into new sectors and geographies through innovative product launches and collaborative programs.

Company News